1,913
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Combining LC–MS/MS and Hollow-Fiber Infection Model For Real-Time Quantitation of Ampicillin to Antimicrobial Resistance

, , &
Article: FSO349 | Received 15 May 2018, Accepted 11 Sep 2018, Published online: 17 Oct 2018

References

  • Servick K. The drug push. Science 348(6237), 850–853 (2015).
  • Ronald AR, Nicolle LE, Stamm E et al. Urinary tract infection in adults: research priorities and strategies. Int. J. Antimicrob. Agents 17(4), 343–348 (2001).
  • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49(2), 53–70 (2003).
  • Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13(5), 269–284 (2015).
  • Regoes RR, Wiuff C, Zappala RM, Garner KN, Baquero F, Levin BR. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob. Agents Chemother. 48(10), 3670–3676 (2004).
  • Maddi S, Kolsum U, Jackson S et al. Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 1507–1518 (2017).
  • Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine (Baltimore) 96(37), e7834 (2017).
  • Peterson SC, Lau TTY, Ensom MHH. Combination of ceftriaxone and ampicillin for the treatment of enterococcal endocarditis: a qualitative systematic review. Ann. Pharmacother. 51(6), 496–503 (2017).
  • Cadwell S. Is your emergency department “kid ready”?. J. Emerg. Nurs. 38(6), 508 (2012).
  • Drusano GL. Pre-clinical in vitro infection models. Curr. Opin. Pharmacol. 36, 100–106 (2017).
  • Raza Siddiqui M, Alothman ZA, Mohammad Wabaidur S. Ultraperformance liquid chromatography–mass spectrometric method for determination of ampicillin and characterization of its forced degradation products. J. Chromatogr. Sci. 52(10), 1273–1280 (2014).
  • Rezende CP, Almeida MP, Brito RB, Nonaka CK, Leite MO. Optimisation and validation of a quantitative and confirmatory LC–MS method for multi-residue analyses of beta-lactam and tetracycline antibiotics in bovine muscle. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 29(4), 541–549 (2012).
  • Brown AN, McSharry JJ, Weng Q et al. In vitro system for modeling influenza A virus resistance under drug pressure. Antimicrob. Agents Chemother. 54(8), 3442–3450 (2010).
  • McSharry JJ, Weng Q, Brown A, Kulawy R, Drusano GL. Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system. Antimicrob. Agents Chemother. 53(6), 2375–2381 (2009).
  • Huang C, Gao J, Miao L. Simultaneous determination of flucloxacillin and ampicillin in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and subsequent application to a clinical study in healthy Chinese volunteers. J. Pharm. Biomed. Anal. 59, 157–161 (2012).